Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGFR2/CD309 Antikörper (AA 1268-1341)

Dieser Anti-VEGFR2/CD309 Antikörper ist ein Kaninchen Polyklonal Antikörper zur Detektion von VEGFR2/CD309 in ELISA und IHC (p). Geeignet für Human, Maus und Ratte.
Produktnummer ABIN7227056
-15% Promotion 2026
530,08 €
623,62 €
Sparen Sie 93,54 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 10 bis 14 Werktagen

Kurzübersicht für VEGFR2/CD309 Antikörper (AA 1268-1341) (ABIN7227056)

Target

Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigen
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reaktivität

  • 340
  • 214
  • 142
  • 17
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 296
  • 67
  • 42
  • 14
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 277
  • 145
Polyklonal

Konjugat

  • 182
  • 34
  • 20
  • 16
  • 14
  • 10
  • 10
  • 8
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser VEGFR2/CD309 Antikörper ist unkonjugiert

Applikation

  • 221
  • 120
  • 111
  • 111
  • 63
  • 35
  • 26
  • 25
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Bindungsspezifität

    • 39
    • 34
    • 26
    • 23
    • 21
    • 16
    • 16
    • 11
    • 11
    • 10
    • 9
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1268-1341

    Verwendungszweck

    VEGFR2 Polyclonal Antibody

    Spezifität

    The antibody detects endogenous VEGFR2.

    Aufreinigung

    The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen

    Immunogen

    Synthetic peptide from human protein at AA range: 1268-1341

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC-P (1:50-1:300), ELISA (1:5000-1:20000).

    Kommentare

    Primary Antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Target

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Andere Bezeichnung

    VEGFR2

    Hintergrund

    Rabbit Anti-VEGFR2 Polyclonal Antibody,Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD antigen CD309,Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. KDR (kinase insert domain receptor) encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc. Mutations of KDR are implicated in infantile capillary hemangiomas.,VEGFR2

    Gen-ID

    3791

    UniProt

    P35968

    Pathways

    RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Sie sind hier:
Chat with us!